![Mario Crovetto](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Mario Crovetto
Directeur/Bestuurslid bij
ALIKO SCIENTIFIC S.A.
Profiel
Mario P.
Crovetto is Director at Ikonisys SA since 2026 and a Member of the Supervisory Board at Curetis GmbH since 2021.
Former roles include Independent Director at OpGen, Inc. from 2020 to 2024, Chief Financial Officer at Eurand NV from 1999 to 2011, CFO and Vice President-Corporate Development at Recordati SpA from 1990 to 1999, and Independent Member of the Supervisory Board at Curetis NV from 2015 to 2020.
Education includes graduate studies at Harvard University and undergraduate studies at Università Cattolica del Sacro Cuore Campus di Milano.
Actieve functies van Mario Crovetto
| Bedrijven | Functie | Begin |
|---|---|---|
| ALIKO SCIENTIFIC S.A. | Directeur/Bestuurslid | 01-07-2021 |
Curetis GmbH
 Curetis GmbH Medical SpecialtiesHealth Technology Develops miniaturized and integrated molecular diagnostic solutions | Directeur/Bestuurslid | - |
Eerdere bekende functies van Mario Crovetto
| Bedrijven | Functie | Einde |
|---|---|---|
| CAPFORCE INC. | Directeur/Bestuurslid | 25-03-2024 |
| CURETIS N.V. | Directeur/Bestuurslid | 01-04-2020 |
Eurand NV
 Eurand NV Pharmaceuticals: MajorHealth Technology Manufactures and commercializes enhanced pharmaceutical and biopharmaceutical products | Financieel Directeur/CFO | 01-01-2011 |
| RECORDATI | Financieel Directeur/CFO | 01-01-1999 |
Opleiding van Mario Crovetto
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
58
Eerstegraads connecties
8
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 8 |
|---|---|
OpGen, Inc.
 OpGen, Inc. Miscellaneous Commercial ServicesCommercial Services Develops technologies against life-threatening, antibiotic-resistant infections using molecular diagnostics and bioinformatics | Commercial Services |
Eurand NV
Eurand NV Pharmaceuticals: MajorHealth Technology Manufactures and commercializes enhanced pharmaceutical and biopharmaceutical products | Health Technology |
Harvard University
 Harvard University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Recordati SpA
 Recordati SpA Pharmaceuticals: MajorHealth Technology Manufactures and markets pharmaceutical products | Health Technology |
Università Cattolica del Sacro Cuore Campus di Milano
 Università Cattolica del Sacro Cuore Campus di Milano Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Curetis GmbH
Curetis GmbH Medical SpecialtiesHealth Technology Develops miniaturized and integrated molecular diagnostic solutions | Health Technology |
Curetis NV
 Curetis NV Medical/Nursing ServicesHealth Services Develops miniaturized and integrated molecular diagnostic solutions | Health Services |
Ikonisys SA
 Ikonisys SA Medical SpecialtiesHealth Technology Manufactures and distributes cellular diagnosis applications for cancer, genetic diseases and fertility problems | Health Technology |
